SAM-e 400mg
Natural health product licensed in Canada
- Licence holder
- GNC Canada Holdings ULC
- NPN or DIN-HM
- 80027030
- Status
- Inactive licence
- Licence date
- 22 August 2011
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| S-adénosylméthionine Source : Disulfate Monotosylate | 400 mg | Not calculated |
Non-medicinal ingredients
Dioxyde de silicium, Citrate de triéthyle, D-Mannitol, triglycérides à chaînes moyennes, Microcrystalline cellulose, Stéarate de magnésium, Glyceryl Palmitostearate, Talc, Copolymère d'acide méthacrylique, Béhénate de glycéryle, Dioxyde de titane
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | minimum: 1 Comprimé ; maximum: 4 Comprimé | 1 Tous les jours |
| Adultes | Not specified | 1 Comprimé | 3 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps support healthy mood balance, liver function, and helps alleviate osteoarthritic pain.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80027030
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.